| The declaration of Helsinki MDE Goodyear, K Krleza-Jeric, T Lemmens Bmj 335 (7621), 624-625, 2007 | 599 | 2007 |
| Research ethics recommendations for whole-genome research: consensus statement T Caulfield, AL McGuire, M Cho, JA Buchanan, MM Burgess, U Danilczyk, ... PLoS biology 6 (3), e73, 2008 | 301 | 2008 |
| The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good K Bardosh, A De Figueiredo, R Gur-Arie, E Jamrozik, J Doidge, ... BMJ Global Health 7 (5), e008684, 2022 | 201 | 2022 |
| 7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials K Krleža-Jerić, T Lemmens Croatian medical journal 50 (2), 105, 2009 | 178 | 2009 |
| Selective justice, genetic discrimination, and insurance: should we single out genes in our laws T Lemmens McGill LJ 45, 347, 2000 | 151 | 2000 |
| Ethics review for sale? Conflict of interest and commercial research review boards T Lemmens, B Freedman The Milbank Quarterly 78 (4), 547-584, 2000 | 135 | 2000 |
| Bioethics for clinicians: 17. Conflict of interest in research, education and patient care T Lemmens, PA Singer CMAJ 159 (8), 960-965, 1998 | 129 | 1998 |
| Leopards in the temple: restoring scientific integrity to the commercialized research scene T Lemmens Journal of Law, Medicine & Ethics 32 (4), 641-657, 2004 | 108 | 2004 |
| The social and cultural shaping of medical evidence: case studies from pharmaceutical research and obstetric science R De Vries, T Lemmens Social science & medicine 62 (11), 2694-2706, 2006 | 105 | 2006 |
| Guinea pigs on the payroll: the ethics of paying research subjects T Lemmens, C Elliott Accountability in research 7 (1), 3-20, 1999 | 94 | 1999 |
| The human subjects trade: Ethical and legal issues surrounding recruitment incentives T Lemmens, PB Miller Journal of Law, Medicine & Ethics 31 (3), 398-418, 2003 | 81 | 2003 |
| Justice for the professional guinea pig T Lemmens, C Elliott American journal of bioethics 1 (2), 51-53, 2001 | 79 | 2001 |
| The OHRP and SUPPORT—another view R Macklin, L Shepherd, A Dreger, A Asch, F Baylis, H Brody, LR Churchill, ... New England Journal of Medicine 369 (2), e3, 2013 | 73 | 2013 |
| Access to information and the right to health: the human rights case for clinical trials transparency T Lemmens, C Telfer American Journal of Law & Medicine 38 (1), 63-112, 2012 | 61 | 2012 |
| Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles S Stern, T Lemmens PLoS medicine 8 (8), e1001070, 2011 | 61 | 2011 |
| Should assisted dying for psychiatric disorders be legalized in Canada? SYH Kim, T Lemmens CMAJ 188 (14), E337-E339, 2016 | 54 | 2016 |
| Should society allow research ethics boards to be run as for-profit enterprises? EJ Emanuel, T Lemmens, C Elliot PLoS Medicine 3 (7), e309, 2006 | 52 | 2006 |
| Pharmaceutical knowledge governance: a human rights perspective T Lemmens Journal of Law, Medicine & Ethics 41 (1), 163-184, 2013 | 47 | 2013 |
| A Comparative Analysis of Research Ethics Review: Mechanisms and the ICH Good Clinical Practice Guideline M Hirtle, T Lemmens, D Sprumont European Journal of Health Law 7 (3), 265-292, 2000 | 47 | 2000 |
| Does the FDA have the authority to trump the Declaration of Helsinki? MDE Goodyear, T Lemmens, D Sprumont, G Tangwa Bmj 338, 2009 | 42 | 2009 |
